Antimicrobial resistance in tuberculosis: an international perspective.
van Helden, Paul D; Donald, Peter R; Victor, Thomas C; Schaaf, H Simon; Hoal, Eileen G; Walzl, Gerhard; Warren, Robin M.
Expert Rev Anti Infect Ther
; 4(5): 759-66, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-17140353
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.
Using Patient Pathway Analysis to Design Patient-centered Referral Networks for Diagnosis and Treatment of Tuberculosis: The Case of the Philippines.
Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.
Estimating the impact of a novel drug regimen for treatment of tuberculosis: a modeling analysis of projected patient outcomes and epidemiological considerations.
Tuberculosis Risk among Medical Trainees, Pune, India.
Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
High prevalence of DR-TB (drug-resistant tuberculosis): An Indicator of public health negligence.
Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study.
Clinical peculiarities of tuberculosis.
Manejo clínico y programático de la tuberculosis con resistencia a fármacos